• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Healthcare·9158.T
Share

CUC Inc. Stocks

¥ 719Last Updated 16.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

¥ 134.69M

¥ 719
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

CUC Inc. delivers a diverse range of healthcare provisions across Japan, throughout Asia, and globally. Their services cover critical areas like inpatient hospital care, specialized dialysis treatments, visiting nurse programs, and home hospice support. Beyond direct patient care, the company also offers essential management assistance to healthcare organizations and provides expert healthcare consulting. Founded in 2014, CUC Inc. is headquartered in Minato-Ku, Japan, and operates as an affiliate of M3 Inc.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 9158.T is 900 and suggests 26.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.10.2026 13:40

Netflix Replaced Its Chief Content Officer After Its Stock Price Fell 40% Over the Past Year

16.10.2026 12:40

CoreWeave's founders protected their fortunes by selling $3.3 billion worth of shares

16.10.2026 11:41

Tesla has unveiled its "flying" Roadster hypercar. How will this change things for the company?

16.10.2026 10:19

Top Stories This Morning: The "Flying" Tesla Roadster, Meta's New Model, and CoreWeave's Risks

16.10.2026 08:00

Pharmaceutical companies benefited from the sell-off in the AI sector. Which stocks are nearing their all-time highs?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026